skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

もっと見る

Products

もっと見る

もっと見る

59 Total results for product and free and sample content found

Citeline

Clinical Trial Webinar Series

Clinical Trial Webinar Series

Learn about the latest trends affecting biopharma R&D including, study diversity & transparency, predictive feasibility and more...

Topic Coronavirus clinical-trials biopharmaceutical

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

2021 Scrip Pharma Trends

For Scrip’s annual preview our journalists asked over 200 industry executives and experts for their predictions of the major trends for 2021. From the pandemic, to AI, therapeutics, and the new US leadership, here’s what to watch out for – in a year with so much at stake.

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Quick Listen: Scrip’s Five Must-Know Things

SC2008_FiveMustKnowThings_1200_Final

A resolution in a long-running patent dispute, expansion of coronavirus vaccine production, drug development trends over the past decade, hematological malignancies in a clinical trial, and the last instalment in the Scrip Asks series all feature in this week's podcast version of Scrip's Five Must-Know Things.

Topic biopharmaceutical

Generics Bulletin: ジェネリック&バイオシミラーニュース

Biocon’s Malaysia Insulin Facility Hit With 12 FDA Observations

Biocon’s Malaysia Insulin Facility Hit With 12 FDA Observations

The US FDA has slapped Biocon with a dozen observations over three units at its insulin manufacturing facility in Malaysia, but the Indian biotech firm says the problems can be remedied quickly and that US launch plans are on track for its insulin product glargine challenging French drug-maker Sanofi’s multi-billion-dollar Lantus.

Topic fda diabetes biopharmaceutical

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

A Positive Outlook For Deals, With Election Year Caveats

Industry advisers at the BIO CEO & Investor meeting remained optimistic about the pharmaceutical deal environment in 2020 – even with the uncertainty around a looming US election year.

Topic biopharmaceutical

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Pfizer And BioNTech Claim COVID19 Vaccine Success

The companies look to have secured a better than expected 90% efficacy level, but will await safety data before filing later this month.

Topic Coronavirus biopharmaceutical

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

UK Votes To Leave The EU – Where Next For The Life Sciences?

UK Votes To Leave The EU – Where Next For The Life Sciences?

UK vote to leave the EU opens the prospect of years of negotiations over the union's future relationship with one of its most valued member states.

Topic Regulation brexit biopharmaceutical

Chemist + Druggist Data

UK Sees PIP Codes Expand To Cover Hospital Drugs

Pharmacists PIP Code Expansion

Chemist + Druggist has expanded its “PIP code” system for UK pharmacy procurement to also encompass hospital drugs.

Topic biopharmaceutical Regulation biosimilars

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。

新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問い合わせの際は下記のフォームまたはメールアドレスをご利用下さい。

Eメール:inquiry.jp@informa.com


オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。